Institutional Ownership Entrada Therapeutics, Inc. (TRDA)
This table provides information about the institutional ownership of Entrada Therapeutics, Inc. (TRDA). We have compiled data on the 107 institutions that hold shares in the stock, with a total of 28.8 Million shares, which have been reported (via 13F filing form) to have a value of $148 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Baker Bros. Advisors LP
New York, NY |
Aug 14, 2025 Q2 2025 |
4,865,819
shares
|
$25 Million
0.33% of portfolio
|
Q2 2022
Added 3.43%
|
|
Mpm Asset Management LLC
Cambridge, MA |
Aug 14, 2025 Q2 2025 |
4,381,062
shares
|
$22.5 Million
67.92% of portfolio
|
Q4 2024
Reduced 1.01%
|
|
5 Am Venture Management, LLC
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
4,308,379
shares
|
$22.1 Million
19.43% of portfolio
|
Q2 2025
Reduced 2.27%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
2,567,478
shares
|
$13.2 Million
0.0% of portfolio
|
Q2 2025
Reduced 6.19%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
1,693,867
shares
|
$8.71 Million
0.0% of portfolio
|
Q2 2024
Added 13.98%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
1,604,860
shares
|
$8.25 Million
0.0% of portfolio
|
Q2 2025
Added 1.86%
|
|
Janus Henderson Group PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
1,521,281
shares
|
$7.82 Million
0.01% of portfolio
|
Q2 2025
Reduced 28.3%
|
|
Wellington Management Group LLP
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,060,716
shares
|
$5.45 Million
0.0% of portfolio
|
Q2 2025
Added 0.7%
|
|
Step Stone Group LP
La Jolla, CA |
Aug 13, 2025 Q2 2025 |
761,277
shares
|
$3.91 Million
12.82% of portfolio
|
Q3 2022
Added 19.89%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
631,554
shares
|
$3.25 Million
0.0% of portfolio
|
Q2 2025
Added 7.21%
|
|
Tcg Crossover Management, LLC
Palo Alto, CA |
Aug 14, 2025 Q2 2025 |
584,955
shares
|
$3.01 Million
0.8% of portfolio
|
Q4 2022
Reduced 8.91%
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
495,862
shares
|
$2.55 Million
0.0% of portfolio
|
Q2 2025
Added 0.3%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
423,985
shares
|
$2.18 Million
0.0% of portfolio
|
Q2 2025
Added 29.61%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
379,500
shares
|
$1.95 Million
0.0% of portfolio
|
Q2 2025
Added 15.53%
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
300,321
shares
|
$1.54 Million
0.0% of portfolio
|
Q2 2025
Reduced 3.18%
|
|
Royce & Associates LP
|
Aug 11, 2025 Q2 2025 |
223,251
shares
|
$1.15 Million
0.02% of portfolio
|
Q2 2025
New holding
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Aug 14, 2025 Q2 2025 |
220,736
shares
|
$1.13 Million
0.01% of portfolio
|
Q2 2025
Added 4.68%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
203,693
shares
|
$1.05 Million
0.0% of portfolio
|
Q2 2025
Added 5.7%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
170,322
shares
|
$875,455
0.0% of portfolio
|
Q2 2025
New holding
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
163,097
shares
|
$838,318
0.0% of portfolio
|
Q2 2025
Added 121.42%
|
|
Qube Research & Technologies LTD
London, X0 |
Aug 14, 2025 Q2 2025 |
133,730
shares
|
$687,372
0.0% of portfolio
|
Q2 2025
Added 435.07%
|
|
Moore Capital Management, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
105,000
shares
|
$539,700
0.01% of portfolio
|
Q4 2021
New holding
|
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
Aug 13, 2025 Q2 2025 |
102,008
shares
|
$524,321
0.0% of portfolio
|
Q2 2025
Reduced 17.67%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
100,357
shares
|
$515,834
0.0% of portfolio
|
Q2 2025
Added 509.96%
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Aug 13, 2025 Q2 2025 |
96,686
shares
|
$496,966
0.0% of portfolio
|
Q2 2025
Reduced 2.06%
|